Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of ...

Resolution Bioscience is a fast-growing, innovative leader in next-generation sequencing (NGS)-based oncology solutions. Combination brings together Resolution Bioscience’s noninvasive liquid biopsy ...

It has been about a month since the last earnings report for Agilent Technologies (A). Shares have added about 0.1% in that time frame, outperforming the S&P 500. Will the recent positive trend ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the company was again named one of the Most JUST Companies in America by Just Capital and CNBC. This marks the ...

Agilent Technologies (A) has been in focus after reporting quarterly results that exceeded analyst expectations on both ...

What Happened? Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 3.9% in the morning session after ...

Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered ...

Valued at a market cap of $34.5 billion, Agilent Technologies, Inc. (A) is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets.

Agilent Technologies' dividend strength, earnings growth, payout sustainability, and business outlook as the company ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) announced today that the U.S. Food and Drug Administration (FDA) has approved Agilent Resolution ctDx FIRST as a companion ...

Hi. Good morning, everyone. This is Rachel Vatnsdal with the Life Science Tools and Diagnostics team here at JPMorgan. I'm joined by the Agilent management team on stage as these sessions typically ...